Delivered January 31, 2020. Contributor: Agnidip M.
To provide an overview of the surgical robotics industry in the United States, with insights focused on key players in the market, new entrants and media outlets covering the industry.
According to market research reports, the key players in the surgical robotics market in the United States are: Intuitive Surgical, Stryker, and Mazor Robotics.
Reportedly these three companies together have the largest installed base of surgical robotic systems across hospitals and ambulatory surgical centers.
Other important players present in this market include the likes of Hansen Medical, Medrobotics, TransEnterix and THINK Surgical.
Docwirenews.com compiled a list of top five robotic surgery systems manufactured mostly by the key players mentioned above. These five were Da Vinci by Intuitive Surgical, Ion by Intuitive Surgical, Mako by Stryker, Navio by Smith & Nephew and Monarch by Auris Health.
New Entrants and Media Coverage
One of the players mentioned in the list above, Medtronics, declared in September 2019 to launch a new robot-assisted surgery platform that could be more flexible and cost-effective than systems presently on the market.
The system was named Hugo RAS and was seen as Medtronic’s answer to a growing market that remains dominated by Intuitive Surgical.
Medtronics has plans to launch the Hugo system during the early months of 2020. This news was reported by the web portal massdevice.com
As an important stricture for new entrants to abide by, FDA in March 2019 issued a warning against the use of surgical robots in mastectomies and other surgeries for the treatment or prevention of cancer. According to the FDA, the safety and effectiveness of surgical robots have not been established for use in mastectomies or for surgeries to prevent or treat breast and other cancers. The news was reported by therobotreport.com.
Only the project owner can select the next research path.